Sanleng Wan inhibits endometriosis progression by regulating sphingolipid metabolism via the S1P/S1PR1-Akt axis based on serum metabolomics and network pharmacology
This study investigates how Sanleng Wan regulates sphingolipid metabolism through the S1P/S1PR1-Akt axis to inhibit endometriosis progression, using serum metabolomics and network pharmacology.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (87)
- Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis via openalex
- [Clinical observation on treatment of endometriosis with principle of activating blood circulation to remove stasis]. via openalex
- Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial via openalex
- Endometriosis via openalex
- Endometriosis is associated with aberrant metabolite profiles in plasma via openalex
- Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology via openalex
- Gas Chromatography–Mass Spectrometry (GC–MS) Metabolites Analysis in Endometriosis Patients: A Prospective Observational Translational Study via openalex
- Identification of key modules and candidate genes associated with endometriosis based on transcriptome data via bioinformatics analysis via openalex
- Integration of 16 S rRNA gene sequencing, metabonomics and metagenome analysis to investigate the mechanism of Sparganium stoloniferum-Curcuma phaeocaulis in treating of endometriosis in rats via openalex
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics via openalex
- Metabolomics in endometriosis: challenges and perspectives for future studies via openalex
- Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology–Based Identification via openalex
- PI3K/AKT signaling pathway associates with pyroptosis and inflammation in patients with endometriosis via openalex
- [Preventive and therapeutic effect of E-leng capsule on post-operation recurrence of ovarian endometriotic cysts and its influence on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in eutopic and ectopic endometrium]. via openalex
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure via openalex
- Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β–induced fibrosis via openalex
- Sphingosine 1-Phosphate (S1P) in the Peritoneal Fluid Skews M2 Macrophage and Contributes to the Development of Endometriosis via openalex
- State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials via openalex
- Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway via openalex
- Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence via openalex
- The role of fibrosis in endometriosis: a systematic review via openalex
- The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis via openalex
- Transforming growth factor beta1 from endometriomas promotes fibrosis in surrounding ovarian tissues via Smad2/3 signaling† via openalex
- UPLC-Q-TOF/MS Based Plasma Metabolomics for Identification of Paeonol’s Metabolic Target in Endometriosis via openalex
- W3134885188 via openalex
- W3162053621 via openalex
- W3202037714 via openalex
- W3207428950 via openalex
- W3209083541 via openalex
- W3212454632 via openalex
- W3217346306 via openalex
- W4206806868 via openalex
- W4214754424 via openalex
- W4220981586 via openalex
- W4294225587 via openalex
- W4296519681 via openalex
- W4308522305 via openalex
- W4309195114 via openalex
- W4362519333 via openalex
- W4362660905 via openalex
- W4368358800 via openalex
- W4386030783 via openalex
- W4387643681 via openalex
- W4389051433 via openalex
- W4390099199 via openalex
- W4392858206 via openalex
- W4393316944 via openalex
- W4395112077 via openalex
- W4399221424 via openalex
- W4401106527 via openalex
- W4403733804 via openalex
- W4407275277 via openalex
- W4407902190 via openalex
- W4408811948 via openalex
- W6683305549 via openalex
- W6697579514 via openalex
- W6706597662 via openalex
- W6715413576 via openalex
- W6797377172 via openalex
- W6857286426 via openalex
- W6862880186 via openalex
- W6863281070 via openalex
- W569534875 via openalex
- W6874137092 via openalex
- W1516047133 via openalex
- W1967409305 via openalex
- W2100678718 via openalex
- W2101386379 via openalex
- W2110283222 via openalex
- W2123245589 via openalex
- W2132260833 via openalex
- W2146276289 via openalex
- W2156673559 via openalex
- W2156754327 via openalex
- W2412473590 via openalex
- W2443594880 via openalex
- W2468194934 via openalex
- W2897589411 via openalex
- W2917075888 via openalex
- W2946955396 via openalex
- W2962348518 via openalex
- W3007580834 via openalex
- W3037908215 via openalex
- W3048569636 via openalex
- W3099546248 via openalex
- W3111099601 via openalex
- W3114418359 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-26T00:31:20.206735+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00